One name, three frequency labels
All three regulators recognise the effect under the same medical term. They differ on how prominently to report it, which reflects how often it turned up in trials rather than any difference in the medicine.
| Document | Where it appears | Frequency given |
|---|---|---|
| US Prescribing Information, revised 05/2026, section 6.1 [1] | Short list of “other adverse reactions” beside fatigue and dizziness | More than 0.4%; no exact percentage |
| US Medication Guide [1] | Not mentioned | — |
| EU summary of product characteristics, section 4.8 [2] | Nervous system disorders | Uncommon: 1 in 1,000 to 1 in 100 |
| EU package leaflet, section 4 [2] | “Change in the way food or drink tastes” | Uncommon, up to 1 in 100 |
| Canadian monograph, sections 7 and 8.3; patient information [3] | Less common trial reactions; also among post-marketing events | Uncommon in patient information; post-marketing frequency unknown |
What “above 0.4%” and “uncommon” mean in practice
The US label gives exact percentages mainly for reactions seen in at least 5% of people, plus a handful of others. Three further reactions associated with Ozempic® at a frequency above 0.4% are grouped in one sentence: fatigue, dysgeusia and dizziness [1]. That tells you taste change was detected in the trials, not how often.
The EU summary is more precise about the band: uncommon, between 1 in 1,000 and 1 in 100 people, from a pool of eight phase 3a trials with 4,792 people on semaglutide up to 1 mg [2]. Headache and dizziness sit one band higher, in common. Canada reaches the same uncommon rating and also notes that dysgeusia has been reported after approval [3].
None of the documents says when taste changes started, whether they followed dose increases or how long they lasted.
Studies point in two directions
A 2025 randomised, placebo-controlled study gave 30 women with obesity and polycystic ovary syndrome semaglutide 1.0 mg once weekly, the same strength as an Ozempic® maintenance dose, for 16 weeks [4]. Using taste strips for sweet, salty, sour and bitter, their overall taste recognition score rose from about 11.9 to 14.4 points, a clear improvement over placebo. Tongue biopsies showed changes in genes linked to taste signalling, and brain scans showed altered responses to food cues [4]. It was a small, single-blinded study in women without diabetes, so it does not rule out unpleasant taste changes in others.
Pharmacovigilance points the other way. A 2025 analysis of the US FDA adverse-event database found significant reporting signals for dysgeusia, loss of smell and dry mouth with semaglutide [5]. Such reports are voluntary and can show that something is reported more often than expected, but not that the medicine caused it or how common it is.
Put together: semaglutide clearly interacts with how taste is processed, and for a minority that may be felt as distortion rather than improvement.
Possible routes to a changed taste
What the label supports: dysgeusia was associated with Ozempic® in the trials [1]. No document explains the mechanism.
What research suggests but has not proven: the semaglutide 1.0 mg study found changes in taste-related gene activity in the tongue and in brain responses to sweet taste [4], which offers a direct route. Indirect routes are also plausible. MedlinePlus lists mouth dryness as a cause of impaired taste [6], and much of what we call taste is really smell, so a stuffy nose or reflux can change flavour too [6][7].
Nausea can also make food seem less appealing. It is listed for Ozempic® in 15.8% on 0.5 mg and 20.3% on 1 mg versus 6.1% on placebo, but the label does not link it to taste [1].
Causes that have nothing to do with Ozempic®
MedlinePlus and the National Institute on Deafness and Other Communication Disorders (NIDCD) list many common causes [6][7]:
- Colds, flu, sinus infections, nasal polyps and sore throats; taste usually returns when the illness passes.
- Dry mouth, gum inflammation, poor oral hygiene and dental problems, including a recent wisdom tooth extraction.
- Other medicines, including some antibiotics, antihistamines, thyroid medicines and lithium.
- Smoking, especially pipes and cigars, and vitamin B12 or zinc deficiency.
- Head injury, ear, nose or throat surgery, and the natural decline in taste after about 60.
What NIH sources suggest
NIDCD suggests using foods with a range of colours and textures, aromatic herbs and spices, and avoiding casseroles and mixed dishes that blur individual flavours [7]. It specifically warns against compensating with extra sugar or salt, which matters for people with diabetes or high blood pressure [7]. MedlinePlus advises stopping smoking and following any dietary changes your provider suggests [6].
Both sources stress diagnosis. If a medicine seems to be the cause, NIDCD notes that changing it may help, but not without your doctor’s direction [7]. A clinician may ask whether all foods taste the same, whether your sense of smell has changed, whether you have switched toothpaste or mouthwash and when you last saw a dentist [6]; a few notes make that visit quicker.
Why it matters more with diabetes
NIDCD points out that a distorted sense of taste can make it harder to stick to diets prescribed for diabetes, and can lead people to eat too little or too much [7]. Ozempic® is prescribed to adults with type 2 diabetes alongside diet and exercise, to bring blood sugar down [1]. If food tastes wrong enough to change what or how much you eat, especially with insulin or a sulfonylurea, that is worth raising with your prescriber rather than waiting for it to pass.
Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
The signs and contact information below come from this article’s sourced guidance.
Emergency
- Swelling of the lips, tongue or throat, or trouble breathing or swallowing
Contact: Stop Ozempic® and get emergency help
Ozempic® Medication Guide [1]